Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when DOCS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: DOCS Doximity, Inc. 8-K

Doximity names Matthew Sonefeldt CFO and Dr. Steven Zatz President, reports Q4 results

Filed May 13, 2026 · Period ending May 13, 2026 · ~1 min read

5 key changes 3 high relevance 3 sections

Key Changes

  • high

    Matthew Sonefeldt appointed CFO effective May 13, 2026, with 25 years of experience including investor relations roles at Docusign, Atlassian, and LinkedIn. He formally becomes Principal Financial Officer June 8, 2026.

  • high

    Dr. Steven L. Zatz appointed President effective May 13, 2026. He brings over 20 years in digital health, most recently as Chairman/CEO of HealthCentral and former President/CEO of WebMD Health Corp.

  • high

    Doximity announced fiscal Q4 and full-year 2026 financial results for period ended March 31, 2026. Actual financial figures are in the attached press release.

  • medium

    Sonefeldt's compensation: $400K base salary, $400K annual bonus, and $12M in RSUs ($9M vesting quarterly over 3 years, $3M vesting annually over 3 years based on performance goals).

  • medium

    Dr. Zatz's compensation: $400K base salary, $500K annual bonus paid quarterly, and $2.7M in RSUs ($1M vesting quarterly over 1 year, $1.7M vesting in 1 year based on performance).

Summary

Doximity made two significant leadership appointments on May 13, 2026, bringing in seasoned executives to fill key roles. Matthew Sonefeldt joins as CFO with deep investor relations experience from high-growth tech companies, while Dr. Steven Zatz becomes President with extensive digital health leadership credentials including his tenure at WebMD.

Both appointments signal potential strategic shifts as the company adds experienced operators to its executive team. The timing coincides with Doximity's fiscal Q4 and full-year 2026 earnings announcement for the period ended March 31, 2026. The compensation packages are notable: Sonefeldt receives $12 million in equity over three years, while Dr. Zatz gets $2.7 million over one year with a faster vesting schedule.

The shorter vesting for the President role may indicate a specific near-term mandate. Investors should watch for strategic direction changes in upcoming earnings calls and investor presentations, particularly around growth initiatives that these experienced executives might drive. The transition from interim CFO Siddharth Sitaram to Sonefeldt completes June 8, 2026.

Section-by-Section Diff

Event · Item 2.02 — Results of Operations and Financial Condition

~100 words

Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.

1 Added
Added Fiscal Q4 and FY2026 earnings announcement high

Added in current filing · verify on EDGAR →

On May 13, 2026, Doximity, Inc. (“Doximity”) issued a press release announcing its financial results for its fiscal quarter and year ended March 31, 2026.

Doximity disclosed financial results for the fiscal quarter and full year ended March 31, 2026 through a press release. The 8-K itself does not contain the actual financial figures; those are in the attached press release (Exhibit 99.1). This is a standard earnings announcement filing.

Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation

~1,000 words

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.

1 Added
Added President appointment high

Added in current filing · verify on EDGAR →

Additionally, the Company announced the appointment of Steven L. Zatz, M.D. as President of the Company, effective May 13, 2026.

Doximity appointed Dr. Steven L. Zatz as President effective May 13, 2026. Dr. Zatz is a physician executive with over two decades in digital health, most recently serving as Chairman and CEO of HealthCentral Corporation and previously as President and CEO of WebMD Health Corp. This adds senior healthcare industry leadership to the executive team.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.

2 Added
Added Q4 and FY2026 earnings announcement high

Added in current filing · verify on EDGAR →

Press Release entitled “Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results dated May 13, 2026”

Doximity filed an 8-K to announce the release of its fourth quarter and full fiscal year 2026 financial results. The actual financial details are contained in the attached press release (Exhibit 99.1), which is not included in this 8-K body text.

Added Interim CFO signature medium

Added in current filing · view on EDGAR →

Siddharth Sitaram Chief Accounting Officer (Principal Accounting Officer and Interim Principal Financial Officer)

The 8-K was signed by Siddharth Sitaram in his capacity as Chief Accounting Officer and Interim Principal Financial Officer. The "Interim" designation suggests the CFO role may be in transition, though no departure or appointment event is disclosed in this filing.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · May 25, 2026 · How we verify